1187 studies on GLP-1 agonist class curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This case highlights a rare but potentially life-threatening adverse event associated with Tirzepatide use, particularly in individuals without pre-existing diabetes. It underscores the critical importance of educatin…
This research provides crucial insights, strongly suggesting that the weight loss achieved with Semaglutide is the primary driver behind its beneficial effects on liver health in patients with Type 2 Diabetes Mellitus…
This real-world evidence strongly reinforces the efficacy and safety of Tirzepatide for managing Type 2 Diabetes and associated metabolic abnormalities in a broader, more diverse patient population than typically seen…
This real-world study is crucial for understanding the practical effectiveness of oral semaglutide in a specific demographic, providing valuable data beyond controlled clinical trials. The findings, once published, co…
Understanding the genetic underpinnings of oral semaglutide response is crucial for advancing personalized medicine in prediabetes and obesity. This research could pave the way for personalized treatment strategies, o…
This ambitious trial holds the potential to transform the management of cardiovascular risk in Type 1 Diabetes, particularly for those at high risk. If successful, the findings could establish a new standard of care a…
This trial holds significant promise as it explores a novel therapeutic strategy for a complex and underserved patient population. If semaglutide proves effective in reducing alcohol intake and smoking, it could offer…
The successful demonstration of bioequivalence between these two Semaglutide concentrations is critically important for manufacturing flexibility and potentially expanding treatment options. This allows Novo Nordisk t…
This study is profoundly significant because GLP-1RAs could offer a dual benefit for Type 2 Diabetes patients, simultaneously managing blood glucose and addressing nicotine dependence, a major and often overlooked com…
The initiation of this Phase IV trial is a significant step, as it explores a novel therapeutic avenue for Idiopathic Intracranial Hypertension (IIH), a condition with limited effective treatments. Tirzepatide, known …
The finding that tirzepatide pharmacokinetics are not significantly altered by renal impairment is highly significant. This suggests that patients with kidney disease, including those with end-stage renal disease (ESR…
This research holds significant promise for a population in dire need of improved treatment options, as patients with schizophrenia and AUD face unique challenges and poorer prognoses. If successful, this study could …
This study is critical because it directly addresses a common clinical scenario: how to optimize treatment for Type 2 Diabetes patients who may not be achieving their goals on existing GLP-1 RA therapy. The expected s…
This trial represents a paradigm shift in Type 1 Diabetes management, potentially transforming daily life for millions by simplifying insulin delivery and reducing mental burden. If successful, tirzepatide could enabl…
Obesity-related male infertility is a growing concern, and current treatments often lack sustained efficacy or adherence. This trial holds the potential to identify a novel and effective pharmacological intervention f…
This study provides crucial real-world evidence suggesting that GLP-1 RAs may not be safe for all patients with Type 2 Diabetes, especially those who have undergone gastrostomy. The observed increase in mortality and …
This comprehensive review solidifies the understanding of GLP-1 RAs as promising therapeutic agents for liver diseases, extending their utility beyond metabolic control. By detailing their impact on both metabolic and…
This case report provides compelling evidence that oral semaglutide could be a highly effective and well-tolerated treatment option for patients with HNF4A-MODY, potentially offering a valuable alternative to traditio…
This research highlights a potentially novel benefit of GLP-1 receptor agonists beyond their established metabolic effects, suggesting they may play a protective role in surgical recovery. The significant reduction in…
This comprehensive update underscores the critical and evolving role of non-invasive tests in the diagnosis and management of Steatotic Liver Disease, marking a significant shift away from reliance on invasive liver b…
This case report holds significant clinical importance as it expands the known adverse event profile of Tirzepatide, alerting clinicians to the possibility of drug-induced liver injury. While such events are rare, rec…
This real-world comparative study provides crucial insights into the relative effectiveness of leading weight loss medications outside of controlled clinical trials. The findings strongly support Tirzepatide's superio…
This study provides critical early insights into the potential cardiovascular protective effects of Tirzepatide, even before the official results of SURPASS-CVOT are released. The predicted 23% MACE reduction is highl…
This research is critically important because it addresses a significant unmet need for overweight type 2 diabetic patients with IBD, a population facing compounded health challenges. Current IBD therapies are often l…
Understanding ethnic differences in drug response is critical for optimizing dosing and ensuring drug safety globally. Data from studies like this help inform appropriate prescribing practices for diverse populations,…
This study is crucial because reducing epicardial fat volume could be a novel therapeutic target for improving outcomes in patients who have suffered a STEMI. Both Dapagliflozin and Semaglutide have demonstrated cardi…
If successful, this study could highlight a novel therapeutic benefit of semaglutide beyond its established roles in glycemic control and weight management. Identifying an effective pharmacological intervention for di…
While specific numerical outcomes from this completed trial (NCT03882970) are not detailed in the provided record, the study's primary objective was to demonstrate the superior efficacy of tirzepatide in improving gly…
This research holds significant promise as tirzepatide could represent an innovative approach to effectively induce weight loss and inhibit tumor growth in obesity-driven endometrial cancer. Given the strong link betw…
The successful integration of Tirzepatide into OUD treatment could represent a paradigm shift in how we manage this complex disorder, offering a much-needed adjunctive therapy beyond current standards. Given Tirzepati…
As an active study (NCT07417618) not yet recruiting, specific results are not available; however, based on existing clinical trial data and the known mechanisms of these drugs, the study is expected to reveal signific…
The findings from this review highlight a novel therapeutic pathway for Alcohol Use Disorder (AUD), leveraging Semaglutide's known effects on appetite and reward systems. Given the significant unmet need for effective…
This comprehensive network meta-analysis provides robust evidence confirming the superior efficacy of GLP-1 receptor agonists in achieving clinically significant weight loss in nondiabetic adults. The findings highlig…
This comprehensive review underscores the significant potential of GLP-1 RAs as novel therapeutic agents for a range of psychiatric disorders, extending their utility beyond metabolic health. Their established safety …
This retraction is a critical reminder of the importance of scientific integrity and rigorous peer review in maintaining the reliability of medical literature. It underscores that any conclusions or recommendations ba…
This case report is significant as it contributes to the emerging understanding of tirzepatide's potential adverse effects, specifically hepatotoxicity. The finding highlights the importance for clinicians to consider…